About the Authors
- Marc D. de Smet
-
* E-mail: mddesmet1@mac.com
Affiliations MicroInvasive Ocular Surgery Center (MIOS sa), Lausanne, Switzerland, Preceyes nv, Einhoven, The Netherlands
- Thijs C. M. Meenink
-
Affiliation Preceyes nv, Einhoven, The Netherlands
- Tom Janssens
-
Affiliation ThromboGenics nv, Leuven, Belgium
- Valerie Vanheukelom
-
Affiliation ThromboGenics nv, Leuven, Belgium
- Gerrit J. L. Naus
-
Affiliation Preceyes nv, Einhoven, The Netherlands
- Maarten J. Beelen
-
Affiliation Preceyes nv, Einhoven, The Netherlands
- Caroline Meers
-
Affiliation Medanex Clinic BVBA, Diest, Belgium
- Bart Jonckx
-
Affiliation ThromboGenics nv, Leuven, Belgium
- Jean-Marie Stassen
-
Affiliation Crystapharm BVBA, Lubbeek, Belgium
Competing Interests
MDdS received grant support from TG and is a patent holder (without royalty) of ocriplasmin. He is also a founding member and chief medical officer of Preceyes NV.
Author Contributions
Conceived and designed the experiments: MDdS BJ JMS. Performed the experiments: MDdS TJ VV CM MJB TCMM. Analyzed the data: BJ MDdS GJLN TCMM MJB. Contributed reagents/materials/analysis tools: BJ. Wrote the paper: MDdS BJ TCMM GJLN.